- 同花顺特色产品
- 〈高级诊股〉全方位深度分析，提供明确投资建议
- 〈舆情监控〉实时监控个股情报
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
迄今为止，共19家主力机构，持仓量总计8349.14万股，占流通A股33.85%
- 波段诊断：
-
技术面诊股
诊断结果：5.9技术面打败了54%的股票
技术面评分前10的股票
近期的平均成本为68.97元，股价在成本下方运行。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为68.97元，股价在成本下方运行。
[{"text":"\u5e73\u5747\u6210\u672c","value":"68.97","date":1623917295,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，跑赢行业平均水平。
[{"date":"2021.06.18","stock":"-0.09","trade":"1.60","ind":"0.77"},{"date":"2021.06.17","stock":"2.04","trade":"0.63","ind":"1.23"},{"date":"2021.06.16","stock":"-2.79","trade":"-1.73","ind":"-2.57"},{"date":"2021.06.15","stock":"-1.00","trade":"-1.10","ind":"-0.86"},{"date":"2021.06.11","stock":"-0.11","trade":"-1.54","ind":"-0.62"},{"date":"2021.06.10","stock":"-0.48","trade":"-0.18","ind":"1.19"},{"date":"2021.06.09","stock":"-1.99","trade":"-0.07","ind":"0.01"},{"date":"2021.06.08","stock":"-1.87","trade":"-1.47","ind":"-0.98"},{"date":"2021.06.07","stock":"3.06","trade":"0.48","ind":"-0.06"},{"date":"2021.06.04","stock":"4.17","trade":"0.57","ind":"0.74"},{"date":"2021.06.03","stock":"-3.00","trade":"-1.24","ind":"-0.65"},{"date":"2021.06.02","stock":"-2.67","trade":"-3.13","ind":"-1.18"},{"date":"2021.06.01","stock":"0.38","trade":"1.10","ind":"0.26"},{"date":"2021.05.31","stock":"0.18","trade":"3.97","ind":"0.97"},{"date":"2021.05.28","stock":"-1.06","trade":"-1.27","ind":"-0.30"},{"date":"2021.05.27","stock":"0.30","trade":"1.39","ind":"0.70"},{"date":"2021.05.26","stock":"-1.73","trade":"0.02","ind":"-0.36"},{"date":"2021.05.25","stock":"-1.65","trade":"2.19","ind":"2.34"},{"date":"2021.05.24","stock":"9.65","trade":"-0.02","ind":"0.62"},{"date":"2021.05.21","stock":"-3.39","trade":"-0.82","ind":"-0.81"},{"date":"2021.05.20","stock":"1.62","trade":"0.59","ind":"0.35"}]
万孚生物,深证成指,医疗器械服务指数
压力支撑
该股压力位为68.91元，支撑位为67.71元。
[{"text":"\u538b\u529b\u4f4d","value":"68.91","date":1623945600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"67.71","date":1623945600,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.6资金面打败了41%的股票
主力控盘前10的股票
行业资金
医疗器械服务行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：06月18日 20:30
| 机构今日流向(万元) | 917.29 | 机构5日流向(万元) | -5021.26 |
| 机构10日流向(万元) | -6526.09 | 机构20日流向(万元) | -11520.74 |
机构持仓
2021-03-31 与 2020-12-31 相比，主力机构持仓量减少3053.47万股，其中基金净减仓1家，主力净减仓318家，请投资者中长期谨慎为宜。
截止2021-03-31，共19家主力机构（基金13家，保险公司1家，一般法人5家），持仓量总计8349.14万股，占流通A股33.85%
其中，基金持仓与2020-12-31相比：
增仓：4家 ，增持 116.51万股
减仓：5家 ，减持 55.57万股
新出现在主力名单中：4家 ，持有800.27万股
从主力名单中消失：322家 ，原持有3418.86万股
其中，基金持仓与2020-12-31相比：
增仓：4家 ，增持 116.51万股
减仓：5家 ，减持 55.57万股
新出现在主力名单中：4家 ，持有800.27万股
从主力名单中消失：322家 ，原持有3418.86万股
消息面诊股
诊断结果：6.1消息面打败了78%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 万孚生物：6月17日融资净买入732.86万元 上
2021-06-18 - 万孚生物股东王继华减持888.06万股 套现约5.
2021-06-17 - 万孚生物：公司向工商银行申请综合授信并为经销商和子
2021-06-17 - 万孚生物拟向银行申请2亿元综合授信额度
2021-06-17 - 万孚生物聘任李文美为总经理
2021-06-17 - 万孚生物拟开展不超过6000万美元的外汇套期保值业
2021-06-17 - 万孚生物实控人减持比例达2% 减持实施完毕
2021-06-17 - 万孚生物：6月16日融资净偿还121.49万元 上
2021-06-17 - 万孚生物6月16日现2笔大宗交易
2021-06-17 - 万孚生物(06月16日)现大宗交易
2021-06-16
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2021-05-28 |
| 一般消息 | 重大事项 | 关联交易 | 2021-04-23 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2021-04-09 |
| 利好 | 分红转增 | 10转3股派5元(含税) | 2021-03-31 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2021-01-18 |
| 一般消息 | 资产重组 | 公司股权转让 | 2020-12-25 |
| 一般消息 | 高管变动 | 个人原因 | 2020-11-17 |
| 一般消息 | 分红转增 | 不分配不转增 | 2020-08-28 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 2条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：2.2行业面打败了5%的股票
医疗器械服务行业最新资金流向
近10日来该行业走势不明显，跑输大盘。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2021.06.18","price":"0.77","value":"1.60"},{"date":"2021.06.17","price":"1.23","value":"0.63"},{"date":"2021.06.16","price":"-2.57","value":"-1.73"},{"date":"2021.06.15","price":"-0.86","value":"-1.10"},{"date":"2021.06.11","price":"-0.62","value":"-1.54"},{"date":"2021.06.10","price":"1.19","value":"-0.18"},{"date":"2021.06.09","price":"0.01","value":"-0.07"},{"date":"2021.06.08","price":"-0.98","value":"-1.47"},{"date":"2021.06.07","price":"-0.06","value":"0.48"},{"date":"2021.06.04","price":"0.74","value":"0.57"},{"date":"2021.06.03","price":"-0.65","value":"-1.24"},{"date":"2021.06.02","price":"-1.18","value":"-3.13"},{"date":"2021.06.01","price":"0.26","value":"1.10"},{"date":"2021.05.31","price":"0.97","value":"3.97"},{"date":"2021.05.28","price":"-0.30","value":"-1.27"},{"date":"2021.05.27","price":"0.70","value":"1.39"},{"date":"2021.05.26","price":"-0.36","value":"0.02"},{"date":"2021.05.25","price":"2.34","value":"2.19"},{"date":"2021.05.24","price":"0.62","value":"-0.02"},{"date":"2021.05.21","price":"-0.81","value":"-0.82"},{"date":"2021.05.20","price":"0.35","value":"0.59"}]
深证成指,医疗器械服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 拱东医疗 | 67.85% | 16.06% | 6.7分 |
| 2 | ST运盛 | 42.53% | 13.51% | 5.7分 |
| 3 | 艾隆科技 | 41.91% | 11.37% | 5.9分 |
| 4 | 赛诺医疗 | 27.21% | -3.20% | 5.3分 |
| 5 | *ST华塑 | 23.43% | 11.74% | 6.1分 |
| 6 | 美迪西 | 20.28% | 8.78% | 6.6分 |
| 8 | 鱼跃医疗 | 16.89% | 7.37% | 6.7分 |
| 10 | 惠泰医疗 | 15.91% | 5.44% | 6.2分 |
| 12 | 国际医学 | 11.83% | 9.67% | 5.0分 |
| 14 | 通策医疗 | 11.44% | -0.41% | 6.2分 |
| 16 | 爱博医疗 | 10.75% | 2.86% | 5.9分 |
| 18 | 阳普医疗 | 10.25% | 5.72% | 6.0分 |
| 20 | 国发股份 | 8.75% | 0.45% | 5.4分 |
| 22 | 爱尔眼科 | 8.16% | -3.46% | 5.6分 |
| 24 | 诺禾致源 | 7.64% | -11.56% | 4.9分 |
| 26 | 盈康生命 | 6.49% | -10.80% | 4.4分 |
| 28 | 欧普康视 | 6.05% | -5.02% | 5.2分 |
| 30 | 药明康德 | 5.50% | -6.54% | 5.4分 |
| 32 | 昊海生科 | 4.38% | 1.19% | 5.5分 |
| 34 | 迪瑞医疗 | 3.75% | -3.49% | 5.6分 |
| 36 | 济民医疗 | 2.49% | -2.07% | 3.5分 |
| 38 | 达安基因 | 2.10% | -4.90% | 5.3分 |
| 40 | 之江生物 | 1.86% | -0.31% | 4.7分 |
| 42 | 天智航 | 1.66% | -6.13% | 3.4分 |
| 44 | 博晖创新 | 1.02% | 0.13% | 4.8分 |
| 46 | 安必平 | 0.62% | -3.16% | 4.5分 |
| 48 | 宝莱特 | 0.22% | -3.79% | 4.2分 |
| 50 | 正海生物 | -0.06% | 6.12% | 6.4分 |
| 52 | 圣湘生物 | -0.57% | -2.64% | 5.0分 |
| 54 | 透景生命 | -1.20% | -2.36% | 5.2分 |
| 56 | 金域医学 | -1.66% | -0.13% | 6.3分 |
| 58 | 康德莱 | -1.89% | -15.88% | 4.2分 |
| 60 | 睿智医药 | -2.00% | -4.48% | 4.8分 |
| 62 | 乐凯胶片 | -2.07% | -4.94% | 5.0分 |
| 64 | 基蛋生物 | -2.65% | -2.55% | 5.4分 |
| 66 | 浩欧博 | -2.94% | -6.03% | 5.3分 |
| 68 | 开立医疗 | -3.09% | 0.91% | 5.1分 |
| 70 | 乐普医疗 | -3.26% | 0.91% | 5.1分 |
| 72 | *ST海医 | -3.81% | -4.04% | 4.9分 |
| 74 | 海泰新光 | -4.18% | 0.70% | 5.7分 |
| 76 | 天臣医疗 | -4.43% | -1.21% | 4.0分 |
| 78 | 赛科希德 | -4.77% | -1.30% | 4.6分 |
| 80 | 奥泰生物 | -4.97% | -2.60% | 4.7分 |
| 82 | 康众医疗 | -5.38% | -0.16% | 4.3分 |
| 84 | 大博医疗 | -5.56% | -1.70% | 5.3分 |
| 86 | 科华生物 | -5.98% | -1.71% | 4.8分 |
| 88 | 贝瑞基因 | -6.20% | -4.08% | 4.4分 |
| 90 | 南卫股份 | -6.83% | -5.03% | 4.2分 |
| 92 | 振德医疗 | -7.64% | -5.83% | 4.9分 |
| 94 | 蓝帆医疗 | -8.14% | 0.82% | 5.5分 |
| 96 | *ST恒康 | -8.54% | -5.14% | 4.9分 |
| 98 | 辰欣药业 | -8.67% | -3.22% | 4.8分 |
| 100 | 海尔生物 | -9.28% | -3.53% | 5.4分 |
| 102 | 三诺生物 | -9.50% | -2.30% | 5.2分 |
| 104 | 科美诊断 | -9.59% | 0.59% | 4.7分 |
| 106 | 迈克生物 | -10.36% | -3.13% | 5.1分 |
| 108 | 楚天科技 | -13.12% | -1.37% | 5.1分 |
| 110 | 山东药玻 | -14.35% | -8.12% | 4.0分 |
| 112 | 正川股份 | -16.34% | -2.85% | 4.9分 |
| 114 | 中红医疗 | -16.49% | -9.93% | 4.9分 |
| 116 | 澳洋健康 | -17.13% | -7.57% | 4.4分 |
| 118 | 美年健康 | -20.92% | -18.39% | 4.3分 |
| 120 | 睿昂基因 | -25.26% | -8.74% | 4.1分 |
| 122 | 亚辉龙 | -31.71% | -12.32% | 4.8分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2021-03-31 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 38/257 ， 31/257。
[{"date":"2021-03-31","value":"5.31","vol":"4.68"},{"date":"2020-12-31","value":"25.04","vol":"19.68"},{"date":"2020-09-30","value":"22.46","vol":"16.28"},{"date":"2020-06-30","value":"18.65","vol":"11.22"},{"date":"2020-03-31","value":"4.30","vol":"1.89"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
5.31 | 25.04 | 22.46 | 18.65 | 4.30 |
| 行业(%) | 4.68 | 19.68 | 16.28 | 11.22 | 1.89 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2021-03-31","value":"70.50","vol":"53.38"},{"date":"2020-12-31","value":"69.02","vol":"53.05"},{"date":"2020-09-30","value":"71.54","vol":"48.99"},{"date":"2020-06-30","value":"70.51","vol":"51.66"},{"date":"2020-03-31","value":"67.39","vol":"46.04"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
70.50 | 69.02 | 71.54 | 70.51 | 67.39 |
| 行业(%) | 53.38 | 53.05 | 48.99 | 51.66 | 46.04 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 101/257 ， 83/257。
[{"date":"2021-03-31","value":"26.27","vol":"156.47"},{"date":"2020-12-31","value":"35.64","vol":"68.23"},{"date":"2020-09-30","value":"52.60","vol":"61.45"},{"date":"2020-06-30","value":"66.01","vol":"49.26"},{"date":"2020-03-31","value":"21.92","vol":"4.25"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
26.27 | 35.64 | 52.60 | 66.01 | 21.92 |
| 行业(%) | 156.47 | 68.23 | 61.45 | 49.26 | 4.25 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2021-03-31","value":"58.84","vol":"1539.52"},{"date":"2020-12-31","value":"63.67","vol":"223.61"},{"date":"2020-09-30","value":"95.04","vol":"179.47"},{"date":"2020-06-30","value":"117.42","vol":"141.11"},{"date":"2020-03-31","value":"34.82","vol":"266.95"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
58.84 | 63.67 | 95.04 | 117.42 | 34.82 |
| 行业(%) | 1539.52 | 223.61 | 179.47 | 141.11 | 266.95 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 35/257 ， 85/257。
[{"date":"2021-03-31","value":"0.16","vol":"0.14"},{"date":"2020-12-31","value":"0.78","vol":"0.61"},{"date":"2020-09-30","value":"0.61","vol":"0.44"},{"date":"2020-06-30","value":"0.47","vol":"0.30"},{"date":"2020-03-31","value":"0.17","vol":"0.09"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.16 | 0.78 | 0.61 | 0.47 | 0.17 |
| 行业(次) | 0.14 | 0.61 | 0.44 | 0.30 | 0.09 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2021-03-31","value":"0.51","vol":"22.23"},{"date":"2020-12-31","value":"2.90","vol":"67.90"},{"date":"2020-09-30","value":"2.50","vol":"44.44"},{"date":"2020-06-30","value":"1.78","vol":"25.49"},{"date":"2020-03-31","value":"0.70","vol":"10.93"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.51 | 2.90 | 2.50 | 1.78 | 0.70 |
| 行业(次) | 22.23 | 67.90 | 44.44 | 25.49 | 10.93 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2021-03-31","value":"2.92","vol":"1.21"},{"date":"2020-12-31","value":"54.95","vol":"28.38"},{"date":"2020-09-30","value":"-22.18","vol":"20.42"},{"date":"2020-06-30","value":"33.06","vol":"23.20"},{"date":"2020-03-31","value":"88.50","vol":"-9.83"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 2.92 | 54.95 | -22.18 | 33.06 | 88.50 |
| 行业 | 1.21 | 28.38 | 20.42 | 23.20 | -9.83 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2021-03-31","value":"","vol":"0.01"},{"date":"2020-12-31","value":"2.88","vol":"3.09"},{"date":"2020-09-30","value":"","vol":"0.11"},{"date":"2020-06-30","value":"0.79","vol":"2.27"},{"date":"2020-03-31","value":"","vol":"0.08"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 2.88 | - | 0.79 | - |
| 行业 | 0.01 | 3.09 | 0.11 | 2.27 | 0.08 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 54/257 ， 57/257。
[{"date":"2021-03-31","value":"3.25","vol":"5.48"},{"date":"2020-12-31","value":"2.86","vol":"4.76"},{"date":"2020-09-30","value":"4.18","vol":"5.36"},{"date":"2020-06-30","value":"2.64","vol":"3.82"},{"date":"2020-03-31","value":"2.42","vol":"3.66"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
3.25 | 2.86 | 4.18 | 2.64 | 2.42 |
| 行业 | 5.48 | 4.76 | 5.36 | 3.82 | 3.66 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2021-03-31","value":"2.44","vol":"4.61"},{"date":"2020-12-31","value":"2.33","vol":"4.08"},{"date":"2020-09-30","value":"3.33","vol":"4.41"},{"date":"2020-06-30","value":"1.96","vol":"3.07"},{"date":"2020-03-31","value":"1.75","vol":"2.99"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
2.44 | 2.33 | 3.33 | 1.96 | 1.75 |
| 行业 | 4.61 | 4.08 | 4.41 | 3.07 | 2.99 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 40/257 ， 44/257。
[{"date":"2021-03-31","value":"29.07","vol":"26.81"},{"date":"2020-12-31","value":"30.48","vol":"28.47"},{"date":"2020-09-30","value":"28.41","vol":"28.55"},{"date":"2020-06-30","value":"26.34","vol":"31.04"},{"date":"2020-03-31","value":"28.33","vol":"27.15"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
29.07 | 30.48 | 28.41 | 26.34 | 28.33 |
| 行业(%) | 26.81 | 28.47 | 28.55 | 31.04 | 27.15 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2021-03-31","value":"0.43","vol":"1.42"},{"date":"2020-12-31","value":"0.46","vol":"1.08"},{"date":"2020-09-30","value":"0.43","vol":"0.82"},{"date":"2020-06-30","value":"0.39","vol":"0.84"},{"date":"2020-03-31","value":"0.44","vol":"0.75"}]
| 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.43 | 0.46 | 0.43 | 0.39 | 0.44 |
| 行业(%) | 1.42 | 1.08 | 0.82 | 0.84 | 0.75 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2021-04-28 | 买入 | 买入 |
| 华泰证券 | 2021-04-27 | 买入 | 买入 |
| 华创证券 | 2021-04-27 | 增持 | 增持 |
| 广发证券 | 2021-04-27 | 买入 | 买入 |
| 中信建投 | 2021-04-27 | 买入 | 买入 |
| 兴业证券 | 2021-04-27 | 增持 | 增持 |
机构预测
机构预测该股2021年每股收益与前一年相同，长期投资价值一般。
[{"date":"2017","yellowRectValue":"2.11","blueLineValue":"","type":""},{"date":"2018","yellowRectValue":"3.08","blueLineValue":"","type":""},{"date":"2019","yellowRectValue":"3.87","blueLineValue":"","type":""},{"date":"2020","yellowRectValue":"6.34","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"8.55","blueLineValue":"1.92","type":"YC"}]